UNICYCIVE THERAPEUTICS INC's ticker is and the CUSIP is 90466Y103. A total of 13 filers reported holding UNICYCIVE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,984,666 | +260.2% | 3,470,541 | +436.1% | 0.26% | +218.8% |
| Q2 2023 | $828,692 | -39.0% | 647,416 | 0.0% | 0.08% | -23.1% |
| Q1 2023 | $1,359,574 | +288.9% | 647,416 | 0.0% | 0.10% | +352.2% |
| Q4 2022 | $349,605 | -16.6% | 647,416 | -8.9% | 0.02% | -14.8% |
| Q3 2022 | $419,000 | -30.9% | 710,542 | -2.6% | 0.03% | -10.0% |
| Q2 2022 | $606,000 | -26.6% | 729,680 | +13.9% | 0.03% | -18.9% |
| Q1 2022 | $826,000 | -41.6% | 640,633 | -6.7% | 0.04% | -26.0% |
| Q4 2021 | $1,415,000 | -28.6% | 686,756 | -1.9% | 0.05% | -19.4% |
| Q3 2021 | $1,981,000 | – | 700,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 3,470,152 | $2,984,331 | 0.33% |
| Nantahala Capital Management | 3,470,541 | $2,984,666 | 0.26% |
| BVF INC/IL | 3,413,563 | $2,935,664 | 0.08% |
| RA Capital Management | 3,470,688 | $2,984,792 | 0.06% |
| TANDEM CAPITAL MANAGEMENT CORP /ADV | 31,000 | $26,660 | 0.01% |
| Virtu Financial LLC | 10,994 | $9 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 52,399 | $45,063 | 0.00% |
| STATE STREET CORP | 35,036 | $30,131 | 0.00% |
| GOLDMAN SACHS GROUP INC | 93,233 | $80,180 | 0.00% |